ABOUT THE EVENT
Date: Wednesday, September 9, 2026 8am–5:45pm PDT
Event Location: San Francisco, California
Spend a day engaging with leaders advancing the future of CNS therapeutics, bringing together scientists, innovators, and decision-makers from across pharma and biotech. That is what the CNS Therapeutics Xchange San Francisco 2026 offers. This invitation-only, highly curated meeting provides access to senior expertise and the opportunity to build meaningful relationships that can influence discovery and clinical strategies in neuroscience.
Across dedicated tracks including Target Discovery, Biomarkers, Blood Brain Barrier, Preclinical Models, and Clinical Development, attendees will explore the key scientific and translational challenges in CNS drug development. Discussions span areas such as target validation, disease heterogeneity, CNS delivery, model translatability, and clinical success factors, all grounded in real-world experience and current industry demands.
The agenda is designed to maximise interaction and value, combining keynote and spotlight presentations, poster sessions, expert-led roundtables, and pre-scheduled one-to-one meetings. Structured networking throughout the day ensures ample opportunity to exchange insights, benchmark approaches, and identify high-value collaborations.
Taking place in San Francisco on Thursday 10th September 2026, at the DoubleTree by Hilton San Francisco Airport Hotel, this Xchange connects a senior community working at the forefront of CNS therapeutics.
Registration is complimentary for qualified attendees.
